Silexion Therapeutics(SLXN.US)

Last Updated 19:00:00 ET
longbridge loading

Silexion Therapeutics Announces 1-for-10 Reverse Share Split

Unusual Whales·
US
SLXN
+1.29%
Unusual Whales·
US
SLXN
+1.29%

Silexion Therapeutics shares are trading lower after the company announced a 1-for-10 reverse share split.

benzinga_article·
US
SLXN
+1.29%
US
IBB
+0.10%
US
BIB
+0.46%
benzinga_article·
US
SLXN
+1.29%
US
IBB
+0.10%
US
BIB
+0.46%

SLXN On Track, IMVT Hits New High, CTEV Eyes Blockbuster Revenue, Big Day Ahead For BDTX

rttnews·
US
HCWB
-3.03%
US
SLXN
+1.29%
US
IMVT
+2.25%
rttnews·
US
HCWB
-3.03%
US
SLXN
+1.29%
US
IMVT
+2.25%

12 Health Care Stocks Moving In Wednesday's Intraday Session

benzinga_article·
US
SLXN
+1.29%
US
HCWB
-3.03%
US
MTVA
-13.43%
benzinga_article·
US
SLXN
+1.29%
US
HCWB
-3.03%
US
MTVA
-13.43%

Nasdaq Gains 100 Points; Target Earnings Top Views

benzinga_article·
US
.IXIC
+0.31%
US
TGT
+1.95%
US
SLXN
+1.29%
benzinga_article·
US
.IXIC
+0.31%
US
TGT
+1.95%
US
SLXN
+1.29%

Silexion Therapeutics | 8-K: FY2026 Q1 Revenue: USD 0

Earnings Watch·
US
SLXN
+1.29%
Earnings Watch·
US
SLXN
+1.29%

Silexion Therapeutics Announces Warrant Inducement Financing Agreement

Tip Ranks·
US
SLXN
+1.29%
US
IHE
-0.34%
US
VHT
-0.12%
Tip Ranks·
US
SLXN
+1.29%
US
IHE
-0.34%
US
VHT
-0.12%

Silexion Therapeutics Corp 1Q 2026: Net loss $2.7M, EPS ($0.85) — 10-Q Summary

TradingView·
US
SLXN
+1.29%
US
IXJ
-0.24%
US
PBE
-0.85%
TradingView·
US
SLXN
+1.29%
US
IXJ
-0.24%
US
PBE
-0.85%

Silexion Therapeutics | 10-Q: FY2026 Q1 Revenue: USD 0

Earnings Watch·
US
SLXN
+1.29%
Earnings Watch·
US
SLXN
+1.29%
© 2026 Longbridge｜Disclaimer